Comparison of the Fatal Toxicity Index of Zopiclone with Benzodiazepines

References

• Mendelson W. B., Jain B. An assessment of short‐acting hypnotics. Drug Saf 1995; 13(4)257–270
   PubMed Web of Science ®Google Scholar
• Goa K. L., Heel R. C. Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic. Drugs 1986; 32(1)48–65
   PubMed Web of Science ®Google Scholar
• Boniface P. J., Martin I. C., Nolan S. L., Tan S. T. Development of a method for the determination of zopiclone in whole blood. J Chromatogr 1992; 584(2)199–206
   PubMed Web of Science ®Google Scholar
• Boniface P. J., Russell S. G. Two cases of fatal zopiclone overdose. J Anal Toxicol 1996; 20(2)131–133
   PubMed Web of Science ®Google Scholar
• Pounder D. J., Davies J. L. Zopiclone poisoning: tissue distribution and potential for postmortem diffusion. Forensic Sci Int 1994; 65(3)177–183
   PubMed Web of Science ®Google Scholar
• Meatherall R. C. Zopiclone fatality in a hospitalised patient. J Forensic Sci 1997; 42(2)340–343
   PubMed Web of Science ®Google Scholar
• Bramness J. G., Arnestad M., Karinen R., Hilberg T. Fatal overdose of zopiclone in an elderly woman with bronchogenic carcinoma. J Forensic Sci 2001; 46(5)1247–1249
   PubMed Web of Science ®Google Scholar
• Shah R., Uren Z., Baker A., Majeed A. Trends in deaths from drug overdose and poisoning in England and Wales 1993–1998. J Public Health Med 2001; 23(3)242–246
   PubMedGoogle Scholar
• Buckley N. A., Whyte I. M., Dawson A. H., McManus P. R., Ferguson N. W. Correlations between prescriptions and drugs taken in self‐poisoning. Implications for prescribers and drug regulation. Med J Aust 1995; 162(4)194–197
   PubMed Web of Science ®Google Scholar
• Buckley N. A., Dawson A. H., Whyte I. M., O'Connell D. L. Relative toxicity of benzodiazepines in overdose. BMJ 1995; 310: 219–221
   PubMed Web of Science ®Google Scholar
• Serfaty M., Masterton G. Fatal poisonings attributed to benzodiazepines in Britain during the 1980s. Br J Psychiatry 1993; 163: 386–393
   PubMed Web of Science ®Google Scholar
• Drummer O. H., Ranson D. L. Sudden death and benzodiazepines. Amer J Foren Med Path 1996; 95(4)283–287
   Google Scholar
• Verstraete A. G., Buylaert W. A., Blondeel L. Use of benzodiazepines in the general population and their involvement in acute self‐poisoning cases. Pharmacoepidemiol Drug Saf 1998; 7(6)403–410
   PubMed Web of Science ®Google Scholar
• Sundquist J., Ekedahl A., Johansson S‐E. Sales of tranquillizers, hypnotics/sedatives and antidepressants and their relationship with underprivileged area score and mortality and suicide rates. Eur J Clin Pharmacol 1996; 51(2)105–109
   PubMed Web of Science ®Google Scholar
• Stata C. STATA for Windows. 6.0 ed. College Station, TX 77840. Stata Corporation, 1999
   Google Scholar
• Capella D. Descriptive tools and analysis. Drug Utilization Studies: Methods and Uses, M. N.G. Dukes. World Health Organization. 1993; 55–78
   Google Scholar
• Buckley N. A., McManus P. R. Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data. BMJ 2002; 325: 1332–1333
   PubMed Web of Science ®Google Scholar
• Marriott S., Tyrer P. Benzodiazepine dependence. Avoidance and withdrawal. Drug Saf 1993; 9(2)93–103
   PubMed Web of Science ®Google Scholar
• Gossop M., Stewart D., Treacy S., Marsden J. A prospective study of mortality among drug misusers during a 4‐year period after seeking treatment. Addiction 2002; 97(1)39–47
   PubMed Web of Science ®Google Scholar
• Jonas J. M., Hearron A. E. Alprazolam and suicidal ideation: a meta‐analysis of controlled trials in the treatment of depression. J Clin Psychopharmacol 1996; 16(3)208–211
   PubMed Web of Science ®Google Scholar
• Isbister G. K., O'Regan L., Sibbritt D., Whyte I. M. Alprazolam is relatively more toxic than other benzo‐ diazepines in overdose. J Toxicol Clin Toxicol 2003; 41(5), (In press)
   Google Scholar
• Williams D., McBride A. J. The drug treatment of alcohol withdrawal symptoms: a systematic review. Alcohol Alcoholism 1998; 33(2)103–115
   PubMed Web of Science ®Google Scholar
• Holbrook A. M., Crowther R., Lotter A., Cheng C., King D. Meta‐analysis of benzodiazepine use in the treatment of insomnia. CMAJ 2000; 162(2)225–233
   PubMed Web of Science ®Google Scholar
• Musch B., Maillard F. Zopiclone, the third generation hypnotic: a clinical overview. Int Clin Psychopharmacol 1990; 5(Suppl 2)147–158
   PubMedGoogle Scholar
• Delahaye C., Ferrand B., Pieddeloup C., Musch B. Post marketing surveillance of zopiclone: interim analysis on the first 10,000 cases in a clinical study in general practice. Int Clin Psychopharmacol 1990; 5(Suppl 2)131–138
   PubMedGoogle Scholar
• Wagner J., Wagner M. L., Hening W. A. Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia. Ann Pharmacother 1998; 32(6)680–691
   PubMed Web of Science ®Google Scholar
• Hajak G. A comparative assessment of the risks and benefits of zopiclone: a review of 15 years' clinical experience. Drug Saf 1999; 21(6)457–469
   PubMed Web of Science ®Google Scholar
• Buckley N. A., McManus P. R. The fatal toxicity index (FTI) of anxiolytic and sedative drugs in the UK (1983–1999). J Toxicol Clin Toxicol 2002; 40: 344
   Google Scholar
• Holbrook A. M., Crowther R., Lotter A., Cheng C., King D. The diagnosis and management of insomnia in clinical practice: a practical evidence‐based approach. CMAJ 2000; 162(2)216–220
   PubMed Web of Science ®Google Scholar
• Ekeberg O., Jacobsen D., Flaaten B., Mack A. Effect of regulatory withdrawal of drugs and prescription recommenations on the pattern of self‐poisonings in Oslo. Acta Med Scand 1987; 221: 483–487
   PubMed Web of Science ®Google Scholar
• White J. M., Irvine R. J. Mechanisms of fatal opioid overdose. Addiction 1999; 94(7)961–972
   PubMed Web of Science ®Google Scholar